In contrast to ER+ disease, the CD44+CD24-/low phenotype was associated with higher tumour grade in ER- cases with 76% of positive tumours being grade 3 compared to 66% of negative cases (P = 0.020). This evidence concerns the gene CD44 and neoplasm.